Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $689.8500 (0.28%) ($689.8500 - $689.8500) on Mon. Apr. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.48% (three month average) | RSI | 50 | Latest Price | $689.8500(0.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.9% a day on average for past five trading days. | Weekly Trend | REGN declines -0.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) DIA(40%) IWD(39%) SPY(38%) XLV(38%) | Factors Impacting REGN price | REGN will decline at least -0.74% in a week (0% probabilities). VIXM(-19%) TBT(-13%) UUP(-8%) VXX(-3%) USO(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.74% (StdDev 1.48%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $709.43 | 5 Day Moving Average | $703.89(-1.99%) | 10 Day Moving Average | $713.69(-3.34%) | 20 Day Moving Average | $709.43(-2.76%) | To recent high | -6.6% | To recent low | 14.5% | Market Cap | $73.144b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |